• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Dual-Energy Spectral in CT Aids in Diagnosis of Acute Gangrenous Appendicitis

Article

Imaging confirms or excludes the presence of gangrenous appendicitis with high sensitivity and specificity.

Scanner

Dual-energy CT with virtual monoenergetic and iodine overlay imaging accurately confirms or excludes the presence of gangrenous appendicitis, according to a study published in the American Journal of Roentgenology.

Researchers from Canada performed a retrospective study to determine if the use of dual-energy spectral techniques in CT can improve accuracy in the diagnosis of acute gangrenous appendicitis.

Related article: CT Technology: An Overview of the Latest Menu

A total of 209 patients with a pathologic diagnosis of appendicitis were included in the study. Two board-certified abdominal radiologists reviewed 120-kV simulated images, 40-keV virtual monoenergetic images, and color-coded iodine overlay images.

The results showed 44 patients (21.0%) had histopathologic results positive for gangrenous appendicitis. Other findings were:

Sensitivity
100% (44/44)
100% (44/44)
22.7% (10/44)
Specificity
81.2% (134/165)
80.0% (132/165)
96.4% (159/165)
PPV
58.7% (44/75)
57.1% (44/77)
62.5% (10/16)
NPV
100% (134/134)
100% (132/132)
82.4% (159/193)
Accuracy
85.2%
84.2%
77.5%
Interobserver agreement
0.99
0.99
0.93

All cases of gangrenous appendicitis had true-positive results of virtual monoenergetic and iodine overlay imaging. There were no false-negative results of virtual monoenergetic or iodine overlay imaging.

The researchers concluded that in cases of suspected appendicitis, dual-energy CT that includes virtual monoenergetic and iodine overlay imaging is accurate for confirming and excluding the presence of gangrenous appendicitis with high sensitivity and specificity.

Related Videos
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Nina Kottler, MD, MS
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Related Content
© 2024 MJH Life Sciences

All rights reserved.